Trials / Completed
CompletedNCT00683176
Effect of Choline Fenofibrate (SLV348) on Macular Edema
Effect of Choline Fenofibrate (SLV348) on Macular Edema Measured by Optical Coherence Tomography in Subjects With Diabetic Macular Edema - a One-year, Placebo-Controlled, Randomized Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Abbott Products · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of choline fenofibrate on the regression of macular edema in eyes of subjects with type 2 diabetes mellitus (T2DM) presenting with diabetic macular edema (DME)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Choline Fenofibrate | 135 mg |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2008-05-23
- Last updated
- 2011-08-26
Locations
21 sites across 10 countries: Bulgaria, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00683176. Inclusion in this directory is not an endorsement.